AU2001285750A1 - Urokinase inhibitors - Google Patents

Urokinase inhibitors

Info

Publication number: AU2001285750A1
Authority: AU; Australia
Prior art keywords: urokinase inhibitors; urokinase; inhibitors
Prior art date: 2000-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001285750A

Other versions

AU2001285750B2 (en

Inventor

Sebastian Kunzel

Andrea Schweinitz

Torsten Steinmetzer

Jorg Sturzebecher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Heidelberg Pharma AG

Medicines Company Leipzig GmbH

Original Assignee

Wilex AG

Medicines Company Leipzig GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-15

Filing date

2001-06-15

Publication date

2002-03-14

2000-06-15 Priority claimed from DE10029014A external-priority patent/DE10029014A1/en

2001-06-15 Application filed by Wilex AG, Medicines Company Leipzig GmbH filed Critical Wilex AG

2002-03-14 Publication of AU2001285750A1 publication Critical patent/AU2001285750A1/en

2005-10-20 Application granted granted Critical

2005-10-20 Publication of AU2001285750B2 publication Critical patent/AU2001285750B2/en

2007-08-09 Assigned to WILEX AG, CURACYTE AG reassignment WILEX AG Request for Assignment Assignors: CURACYTE AG

2011-03-31 Assigned to THE MEDICINES COMPANY (LEIPZIG) GMBH, WILEX AG reassignment THE MEDICINES COMPANY (LEIPZIG) GMBH Request for Assignment Assignors: CURACYTE AG, WILEX AG

2021-06-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001285750A 2000-06-15 2001-06-15 Urokinase inhibitors Ceased AU2001285750B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10029014A DE10029014A1 (en)	2000-06-15	2000-06-15	Urokinase inhibitors
DE10029014.0		2000-06-15
PCT/EP2001/006789 WO2001096286A2 (en)	2000-06-15	2001-06-15	Urokinase inhibitors

Publications (2)

Publication Number	Publication Date
AU2001285750A1 true AU2001285750A1 (en)	2002-03-14
AU2001285750B2 AU2001285750B2 (en)	2005-10-20

Family

ID=7645521

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU8575001A Pending AU8575001A (en)	2000-06-15	2001-06-15	Urokinase inhibitors
AU2001285750A Ceased AU2001285750B2 (en)	2000-06-15	2001-06-15	Urokinase inhibitors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU8575001A Pending AU8575001A (en)	2000-06-15	2001-06-15	Urokinase inhibitors

Country Status (8)

Country	Link
US (1)	US6831196B2 (en)
EP (1)	EP1294742B1 (en)
JP (1)	JP4105540B2 (en)
AT (1)	ATE263186T1 (en)
AU (2)	AU8575001A (en)
CA (1)	CA2411981C (en)
DE (2)	DE10029014A1 (en)
WO (1)	WO2001096286A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE517910T1 (en) *	2000-08-11	2011-08-15	Wilex Ag	NON-COVALENT INHIBITORS OF UROKINASE AND BLOOD VESSEL FORMATION
CA2387002A1 (en) *	2000-08-11	2002-02-21	Wilex Ag	Non-covalent inhibitors of urokinase and blood vessel formation
CA2470078C (en) *	2001-12-12	2011-07-12	Wilex Ag	Selective urokinase inhibitors
US7838560B2 (en)	2002-03-11	2010-11-23	The Medicines Company (Leipzig) Gmbh	Urokinase inhibitors, production and use thereof
DE10225876A1 (en) *	2002-06-11	2003-12-24	Wilex Ag	Guanidinophenylalanine compounds as urokinase inhibitors
DE10301300B4 (en) *	2003-01-15	2009-07-16	Curacyte Chemistry Gmbh	Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
DE10323898A1 (en)	2003-05-26	2004-12-23	Wilex Ag	Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
GB0320345D0 (en)	2003-08-29	2003-10-01	Syngenta Participations Ag	Organic compounds
DE10342108A1 (en)	2003-09-11	2005-04-14	Curacyte Chemistry Gmbh	Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use
EP1604656A1 (en)	2004-06-09	2005-12-14	Schwarz Pharma Ag	Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
US7552841B2 (en)	2005-05-27	2009-06-30	Prairie Packaging, Inc.	Reinforced plastic foam cup, method of and apparatus for manufacturing same
ES2329286T3 (en)	2005-06-24	2009-11-24	Wilex Ag	USE OF UROQUINASE INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF NEUROPATHOLOGICAL DISEASES.
WO2007025718A1 (en) *	2005-08-29	2007-03-08	Wilex Ag	Oxadiazole compounds as urokinase inhibitors
DE102005044319A1 (en)	2005-09-16	2007-03-22	Curacyte Chemistry Gmbh	2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa
DE102006050672A1 (en) *	2006-10-24	2008-04-30	Curacyte Discovery Gmbh	New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
JP2010536892A (en) *	2007-08-31	2010-12-02	ディーエスエムアイピーアセッツビー．ブイ．	4-Amidinobenzylamine for cosmetic and / or dermatological use
CL2008003653A1 (en) *	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
DE102009022794A1 (en) *	2009-05-27	2010-12-02	Philipps-Universität Marburg	Use of inhibitors of HAT and TMPRSS2 as drugs
ES2483802T3 (en)	2010-07-07	2014-08-07	The Medicines Company (Leipzig) Gmbh	Serine protease inhibitors
WO2012083436A1 (en)	2010-12-21	2012-06-28	The Medicines Company (Leipzig) Gmbh	Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
WO2014009862A2 (en) *	2012-07-12	2014-01-16	Dsm Ip Assets B.V.	Cosmetic composition comprising benzylsulfonyl-d-ser-homophe-(4-amidino-benzylamide) and a polyalcohol
EP2960232A1 (en)	2014-06-25	2015-12-30	DSM IP Assets B.V.	Process for the production of a dipeptide derivative
EP3170832A1 (en) *	2015-11-17	2017-05-24	Centre National De La Recherche Scientifique	Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-d-mannose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0183271B1 (en)	1984-11-30	1990-05-16	Shosuke Okamoto	Lysin derivative and proteinase inhibitor
DE4243858A1 (en) *	1992-12-23	1994-06-30	Thomae Gmbh Dr K	Amino acid derivatives, medicaments containing these compounds and processes for their preparation
SE9301916D0 (en)	1993-06-03	1993-06-03	Ab Astra	NEW PEPTIDES DERIVATIVES
US5550213A (en)	1993-12-27	1996-08-27	Rutgers, The State University Of New Jersey	Inhibitors of urokinase plasminogen activator
CA2258915A1 (en) *	1996-06-25	1997-12-31	Michael Robert Wiley	Anticoagulant agents
ZA986594B (en)	1997-07-25	1999-01-27	Abbott Lab	Urokinase inhibitors
EP1264828B1 (en) *	1998-07-20	2004-04-14	Wilex AG	Inhibitor of urokinase
US6576613B1 (en)	1998-07-24	2003-06-10	Corvas International, Inc.	Title inhibitors of urokinase

2000
- 2000-06-15 DE DE10029014A patent/DE10029014A1/en not_active Withdrawn
2001
- 2001-06-15 EP EP01964989A patent/EP1294742B1/en not_active Expired - Lifetime
- 2001-06-15 AU AU8575001A patent/AU8575001A/en active Pending
- 2001-06-15 CA CA2411981A patent/CA2411981C/en not_active Expired - Fee Related
- 2001-06-15 AT AT01964989T patent/ATE263186T1/en not_active IP Right Cessation
- 2001-06-15 WO PCT/EP2001/006789 patent/WO2001096286A2/en not_active Ceased
- 2001-06-15 AU AU2001285750A patent/AU2001285750B2/en not_active Ceased
- 2001-06-15 US US10/297,557 patent/US6831196B2/en not_active Expired - Lifetime
- 2001-06-15 DE DE50101858T patent/DE50101858D1/en not_active Expired - Lifetime
- 2001-06-15 JP JP2002510430A patent/JP4105540B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
AU2002219555A1 (en)	2003-01-23	VLA-4 Inhibitors
AU2001269836A1 (en)	2002-01-02	Proteases
AU2001285750A1 (en)	2002-03-14	Urokinase inhibitors
AU2001237041A1 (en)	2001-11-08	Kinase inhibitors
AU2001244399A1 (en)	2001-10-23	Gamma-secretase inhibitors
AU2002220241A1 (en)	2002-06-11	Parb inhibitors
AU2001234088A1 (en)	2001-11-08	TNF-alpha inhibitors
AU2002211663A1 (en)	2002-04-22	Nf-$g(k)b inhibitors
AU2001247589A1 (en)	2001-10-03	Non-amidine containing protease inhibitors
AU6007200A (en)	2001-02-19	Cysteine protease inhibitors
AU2001294557A1 (en)	2002-03-26	Thrombin inhibitors
AU5248800A (en)	2001-09-24	Fading inhibitors
AU9059798A (en)	2000-04-10	Urokinase inhibitors
AU2001236052A1 (en)	2001-11-29	Urease inhibitors
AU2002211662A1 (en)	2002-04-22	Nf-kappab inhibitors
AU2002222627A1 (en)	2002-06-24	Tak1 inhibitors
GB0030284D0 (en)	2001-01-24	Enzyme inhibitors
AU2002239753A1 (en)	2002-05-21	Proteases
AU2001232245A1 (en)	2001-08-20	Tnf- alpha inhibitors
AU1588901A (en)	2001-06-06	Protease inhibitors
AU2001247483A1 (en)	2001-10-03	Proteases
AU2001266176A1 (en)	2002-01-14	Methods
AU1474801A (en)	2001-06-06	Protease inhibitors
AU2001278997A1 (en)	2002-02-13	Thrombin inhibitors